RenovoRx Management
Management criteria checks 4/4
RenovoRx's El consejero delegado es Shaun Bagai , nombrado en Jun 2014, tiene un mandato de 9.5 años. la remuneración anual total es $841.07K , compuesta por 58.9% salario y 41.1% primas, incluidas acciones y opciones de la empresa. posee directamente 2.35% de las acciones de la empresa, por valor de $161.00K . La antigüedad media del equipo directivo y del consejo de administración es de 1.4 años y 5.6 años respectivamente.
Key information
Shaun Bagai
Chief executive officer
US$841.1k
Total compensation
| CEO salary percentage | 58.9% |
| CEO tenure | 9.8yrs |
| CEO ownership | 1.7% |
| Management average tenure | 9.8yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
Is RenovoRx (NASDAQ:RNXT) In A Good Position To Invest In Growth?
Mar 31
Companies Like RenovoRx (NASDAQ:RNXT) Could Be Quite Risky
Dec 16RenovoRx reports Q2 results
Aug 15Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?
Aug 04RenovoRx names new finance CFO
Jul 19RenovoRx (NASDAQ:RNXT) Is In A Good Position To Deliver On Growth Plans
Mar 16We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth
Nov 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$9m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$10m |
| Dec 31 2022 | US$841k | US$495k | -US$10m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$9m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | US$988k | US$323k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$253k | US$253k | -US$4m |
| Dec 31 2019 | US$270k | US$240k | -US$4m |
Compensación vs. Mercado: La compensación total de Shaun ($USD841.07K) es aproximadamente el promedio para empresas de tamaño similar en el mercado US ($USD738.70K).
Compensación vs. Ingresos: La compensación de Shaun ha sido consistente con los resultados de la empresa en el último año.
CEO
Shaun Bagai (46 yo)
9.8yrs
Tenure
US$841,074
Compensation
Mr. Shaun R. Bagai has been the Chief Executive Officer and Director of RenovoRx, Inc. since June 2014. He joined RenovoRx in June 2014 and in his first few months has been preparing the RenovoRx for the l...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.9yrs | US$434.66k | 0.28% $ 59.8k | |
| CEO & Director | 9.8yrs | US$841.07k | 1.74% $ 368.6k | |
| VP, Controller & Principal Accounting Officer | 1.8yrs | no data | no data | |
| Chief Clinical Officer | no data | no data | no data |
9.8yrs
Average Tenure
54.5yo
Average Age
Equipo directivo experimentado: RNXTEl equipo directivo de la empresa es veterano y experimentado (9.8 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 5.9yrs | US$434.66k | 0.28% $ 59.8k | |
| CEO & Director | 9.8yrs | US$841.07k | 1.74% $ 368.6k | |
| Independent Director | 11.3yrs | US$102.10k | 0% $ 0 | |
| Independent Director | 11.3yrs | US$97.10k | 0.20% $ 42.4k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 0.24% $ 51.6k | |
| Member of Advisory Board | 6.8yrs | no data | no data | |
| Member of Advisory Board | 6.8yrs | no data | no data | |
| Independent Director | 5.6yrs | US$102.10k | 0.24% $ 51.6k | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
6.3yrs
Average Tenure
66.5yo
Average Age
Junta con experiencia: La junta directiva de RNXT se considera experimentada (5.6 años de antigüedad promedio).